{"id":301435,"date":"2026-10-12T11:28:18","date_gmt":"2026-10-12T05:58:18","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=301435"},"modified":"2026-10-12T11:28:18","modified_gmt":"2026-10-12T05:58:18","slug":"zyduslife-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/","title":{"rendered":"Is Zydus Lifesciences the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Zydus Lifesciences CMP Rs 1,119 (12 Oct 2026). Market cap Rs 1,11,232 Cr. ROE 18.59%. P\/E 24.22x versus Industry P\/E 36.69x.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Zydus Lifesciences is one of the names investors compare when screening the Healthcare sector, built on a 18.59% return on equity and a P\/E of 24.22x against an Industry P\/E of 36.69x. Whether Zydus Lifesciences is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences<\/a> the best stock in its sector? The stock trades on the NSE at Rs 1,119 as of 12 October 2026, within its 52-week range of Rs 835.50 to Rs 1,232.10. Zydus Lifesciences Ltd, based in Ahmedabad and formerly known as Cadila Healthcare, is a global pharmaceutical company with generics, branded formulations, APIs, consumer wellness and animal health businesses.<\/p>\n<p>Zydus Lifesciences sits in the Healthcare sector, and its 18.59% ROE and 24.22x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector&#8217;s Industry P\/E benchmark.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/abbott-india-best-stock-in-its-sector\">Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=zyduslife-best-stock-in-its-sector\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#About_Zydus_Lifesciences\" title=\"About Zydus Lifesciences\">About Zydus Lifesciences<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#Is_Zydus_Lifesciences_the_Best_Stock_in_Its_Sector\" title=\"Is Zydus Lifesciences the Best Stock in Its Sector?\">Is Zydus Lifesciences the Best Stock in Its Sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#How_Zydus_Lifesciences_Compares_Against_Its_Healthcare_Sector_Peers\" title=\"How Zydus Lifesciences Compares Against Its Healthcare Sector Peers\">How Zydus Lifesciences Compares Against Its Healthcare Sector Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#What_Makes_Zydus_Lifesciences_Worth_Watching_in_Healthcare\" title=\"What Makes Zydus Lifesciences Worth Watching in Healthcare\">What Makes Zydus Lifesciences Worth Watching in Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#Zydus_Lifesciences_Valuation_Is_It_Justified\" title=\"Zydus Lifesciences Valuation: Is It Justified?\">Zydus Lifesciences Valuation: Is It Justified?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#How_to_Track_Zydus_Lifesciences_Before_You_Invest\" title=\"How to Track Zydus Lifesciences Before You Invest\">How to Track Zydus Lifesciences Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#Is_Zydus_Lifesciences_the_best_stock_in_its_sector\" title=\"Is Zydus Lifesciences the best stock in its sector?\">Is Zydus Lifesciences the best stock in its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#What_is_the_current_share_price_of_Zydus_Lifesciences\" title=\"What is the current share price of Zydus Lifesciences?\">What is the current share price of Zydus Lifesciences?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#What_sector_does_Zydus_Lifesciences_belong_to\" title=\"What sector does Zydus Lifesciences belong to?\">What sector does Zydus Lifesciences belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#How_does_Zydus_Lifesciences_compare_to_its_sector_peers_on_PE\" title=\"How does Zydus Lifesciences compare to its sector peers on P\/E?\">How does Zydus Lifesciences compare to its sector peers on P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#What_is_Zydus_Lifesciencess_return_on_equity\" title=\"What is Zydus Lifesciences&#8217;s return on equity?\">What is Zydus Lifesciences&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/zyduslife-best-stock-in-its-sector\/#Should_I_invest_in_Zydus_Lifesciences_based_on_its_sector_position\" title=\"Should I invest in Zydus Lifesciences based on its sector position?\">Should I invest in Zydus Lifesciences based on its sector position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Zydus_Lifesciences\"><\/span><strong>About Zydus Lifesciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus Lifesciences Ltd, based in Ahmedabad and formerly known as Cadila Healthcare, is a global pharmaceutical company with generics, branded formulations, APIs, consumer wellness and animal health businesses. It has a significant presence in the US generics market and has invested in vaccines and speciality and biologics pipelines. The stock trades about 9 percent below its 52-week high and about 34 percent above its 52-week low. At a market capitalisation of Rs 1,11,232 Cr, it is tracked as part of the Healthcare sector on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Zydus_Lifesciences_the_Best_Stock_in_Its_Sector\"><\/span><strong>Is Zydus Lifesciences the Best Stock in Its Sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus Lifesciences makes its case as the best stock in its sector primarily on valuation relative to its Industry P\/E, combining a 18.59% ROE with a 24.22x P\/E against the sector&#8217;s 36.69x Industry P\/E. Zydus Lifesciences&#8217; 24.22x P\/E is well below the 36.69x Industry P\/E and is paired with an 18.59% ROE and a 0.46 debt to equity ratio, although its 0.09% dividend yield is small and pharma earnings can swing with US pricing.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Metric<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Zydus Lifesciences<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CMP (NSE)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 1,119.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">52-Week High \/ Low<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 1,232.10 \/ Rs 835.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Market Cap<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 1,11,232 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/E (TTM) vs Industry P\/E<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">24.22x vs 36.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/B<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4.10<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">ROE<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18.59%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 46.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.46<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Zydus Lifesciences Against Other Healthcare Sector Stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Zydus_Lifesciences_Compares_Against_Its_Healthcare_Sector_Peers\"><\/span><strong>How Zydus Lifesciences Compares Against Its Healthcare Sector Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets Zydus Lifesciences against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P\/E, ROE and debt to equity, calculated across the 2 peer companies.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\">Zydus Lifesciences<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,11,232<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">24.22<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18.59%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.46<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lupin\/lupin-ltd-share-price-today\">Lupin<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">89,629<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">16.15<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">23.76%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.29<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">62,954<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">28.56<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">16.66%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>Peer average (2 companies)<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">&#8211;<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>22.35<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>20.21%<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>0.22<\/strong><\/td>\n<\/tr>\n<\/table>\n<p>Against this peer set, Zydus Lifesciences&#8217;s 18.59% ROE is below the 20.21% peer average, and its P\/E of 24.22x runs above the peer average of 22.35x. Zydus Lifesciences&#8217; 24.22x P\/E is well below the 36.69x Industry P\/E and is paired with an 18.59% ROE and a 0.46 debt to equity ratio, although its 0.09% dividend yield is small and pharma earnings can swing with US pricing.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_Zydus_Lifesciences_Worth_Watching_in_Healthcare\"><\/span><strong>What Makes Zydus Lifesciences Worth Watching in Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Valuation gap:<\/strong> A 24.22x P\/E against a 36.69x Industry P\/E is a clear discount to the sector benchmark.<\/li>\n<li><strong>Return ratios:<\/strong> An 18.59% ROE shows healthy profitability on equity.<\/li>\n<li><strong>Scale:<\/strong> A market capitalisation of Rs 1,11,232 Cr makes it one of the larger listed pharma companies.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_Valuation_Is_It_Justified\"><\/span><strong>Zydus Lifesciences Valuation: Is It Justified?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus Lifesciences&#8217; 24.22x P\/E is well below the 36.69x Industry P\/E and is paired with an 18.59% ROE and a 0.46 debt to equity ratio, although its 0.09% dividend yield is small and pharma earnings can swing with US pricing. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/vipclothng-best-stock-in-its-sector\">Is VIP Clothing the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Zydus Lifesciences and other Healthcare sector stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Track_Zydus_Lifesciences_Before_You_Invest\"><\/span><strong>How to Track Zydus Lifesciences Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding whether Zydus Lifesciences deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.<\/p>\n<ol>\n<li>Open the Univest Screener and search for Zydus Lifesciences to view live price, valuation ratios, and peer comparisons within the Healthcare sector.<\/li>\n<li>Compare its P\/E, P\/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.<\/li>\n<li>Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.<\/li>\n<li>Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus Lifesciences earns a place in the best stock in its sector conversation on the strength of a 18.59% ROE and a P\/E of 24.22x against a 36.69x Industry P\/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Zydus_Lifesciences_the_best_stock_in_its_sector\"><\/span><strong>Is Zydus Lifesciences the best stock in its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences has a 18.59% ROE and trades at 24.22x P\/E against a 36.69x Industry P\/E, and compares below the peer average ROE of 20.21% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Zydus_Lifesciences\"><\/span><strong>What is the current share price of Zydus Lifesciences?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences was trading at Rs 1,119.30 on the NSE as of 12 October 2026, within its 52-week range of Rs 835.50 to Rs 1,232.10.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Zydus_Lifesciences_belong_to\"><\/span><strong>What sector does Zydus Lifesciences belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences is classified under the Healthcare sector on Univest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Zydus_Lifesciences_compare_to_its_sector_peers_on_PE\"><\/span><strong>How does Zydus Lifesciences compare to its sector peers on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences&#8217;s P\/E of 24.22x is above the 22.35x average of the 2 named peers compared in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Zydus_Lifesciencess_return_on_equity\"><\/span><strong>What is Zydus Lifesciences&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences reported a return on equity of 18.59%, which is below the 20.21% average of its named peers in this comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Zydus_Lifesciences_based_on_its_sector_position\"><\/span><strong>Should I invest in Zydus Lifesciences based on its sector position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus Lifesciences&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.<\/p>\n<p>{&#8220;@context&#8221;: &#8220;https:\/\/schema.org&#8221;, &#8220;@type&#8221;: &#8220;FAQPage&#8221;, &#8220;mainEntity&#8221;: [{&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;Is Zydus Lifesciences the best stock in its sector?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Zydus Lifesciences has a 18.59% ROE and trades at 24.22x P\/E against a 36.69x Industry P\/E, and compares below the peer average ROE of 20.21% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;What is the current share price of Zydus Lifesciences?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Zydus Lifesciences was trading at Rs 1,119.30 on the NSE as of 12 October 2026, within its 52-week range of Rs 835.50 to Rs 1,232.10.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;What sector does Zydus Lifesciences belong to?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Zydus Lifesciences is classified under the Healthcare sector on Univest.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;How does Zydus Lifesciences compare to its sector peers on P\/E?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Zydus Lifesciences&#8217;s P\/E of 24.22x is above the 22.35x average of the 2 named peers compared in this article.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;What is Zydus Lifesciences&#8217;s return on equity?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Zydus Lifesciences reported a return on equity of 18.59%, which is below the 20.21% average of its named peers in this comparison.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;Should I invest in Zydus Lifesciences based on its sector position?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Zydus Lifesciences&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.&#8221;}}]}<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Is Zydus Lifesciences the best stock in its Healthcare sector? A data-driven comparison against named peers on P\/E, ROE and more.<\/p>\n","protected":false},"author":38,"featured_media":301434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[5839,1019],"class_list":["post-301435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-sector-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["301434"],"rank_math_title":["Is Zydus Lifesciences the Best Stock in Its Sector? A Look at the Numbers"],"rank_math_description":["Is Zydus Lifesciences the best stock in its Healthcare sector? A data-driven comparison against named peers on P\/E, ROE and more."],"rank_math_focus_keyword":["Is Zydus Lifesciences the Best Stock in Its Sector? A Look at the Numbers"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/is-zydus-lifesciences-the-best-stock-in-its-sector-a-look-at-the-numbers.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/301435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=301435"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/301435\/revisions"}],"predecessor-version":[{"id":301436,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/301435\/revisions\/301436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/301434"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=301435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=301435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=301435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}